CamusA (1955) The Myth of Sisyphus. London: Hamish Hamilton.
2.
HøjlundMKöhler-ForsbergOGregersenAT, et al. (2024) Prevalence, correlates, tolerability-related outcomes, and efficacy-related outcomes of antipsychotic polypharmacy: A systematic review and meta-analysis. The Lancet. Psychiatry11: 975–989.
3.
JohnsonSDalton-LockeCBakerJ, et al. (2022) Acute psychiatric care: Approaches to increasing the range of services and improving access and quality of care. World Psychiatry21: 220–236.
4.
KirkbrideJBAnglinDMColmanI, et al. (2024) The social determinants of mental health and disorder: Evidence, prevention and recommendations. World Psychiatry23: 58–90.
5.
PatonCBarnesTRCavanaghMR, et al. (2008) High-dose and combination antipsychotic prescribing in acute adult wards in the UK: The challenges posed by p.r.n. prescribing. The British Journal of Psychiatry192: 435–439.
6.
TaylorDBarnesTREYoungAH (2021) The Maudsley Prescribing Guidelines in Psychiatry. Hoboken, NJ: Wiley.
7.
TiihonenJTanskanenAMittendorfer-RutzE, et al. (2025) Effectiveness of clozapine augmentation with specific doses of other antipsychotics in schizophrenia: a meta-analysis from two nationwide cohorts. World Psychiatry24: 250–259.
8.
TungarazaTEZahidUVenkataramaiahB (2011) Polypharmacy and high-dose antipsychotics at the time of discharge from acute psychiatric wards. The Psychiatrist35: 288–292.
9.
WagnerEKaneJMCorrellCU, et al. (2020) Clozapine combination and augmentation strategies in patients with Schizophrenia-recommendations from an international expert survey among the Treatment Response and Resistance in Psychosis (TRRIP) working group. Schizophrenia Bulletin46: 1459–1470.
